
- Volume 0 0
Xenical
Roche (Nutley, NJ) recently announcedthat the FDA has approved labeling foruse of the prescription weight-loss medicationXenical (orlistat) in the managementof obese adolescents aged 12 to 16years. This approval offers physicians andparents of overweight and obese adolescentsa safe and effective treatment optionto help manage their weight. Xenicalworks locally in the stomach to preventdietary fat absorption by approximately30%. It helps the patient lose weight aswell as maintain the weight loss. For moreinformation, visit www.xenical.com.
Articles in this issue
almost 22 years ago
Interface Speeds Up Prescription Fillingalmost 22 years ago
New Technologies Top Surveyalmost 22 years ago
Partnership Addresses Packaging Solutionsalmost 22 years ago
PDX Software Gets High Marksalmost 22 years ago
Polar Powder Cold Pak with Magnetic Therapyalmost 22 years ago
Seal•ONalmost 22 years ago
SaltAire Sinus Reliefalmost 22 years ago
Zim's Crack Creme Hand Sanitizeralmost 22 years ago
CoroWise Plant Sterolsalmost 22 years ago
CulturelleNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.












































































































































































































